Parker Waichman LLP Headlines by Topic
Tysabri
Biogen Idec Restarts Tysabri Updates
Jan 25, 2010
| Parker Waichman LLP
The maker of Tysabri will once again provide monthly updates regarding new cases of progressive multifocal leukoencephalopathy, or PML, an often...
Tysabri Getting More Scrutiny Over Brain Infection
Oct 26, 2009
| Parker Waichman LLP
European regulators are taking another look at Tysabri. According to The Wall Street Journal, the European Medicines Agency's Committee for...
Tysabri-PML Link Will Weigh on Biogen Stock, Report Says
Sep 23, 2009
| Parker Waichman LLP
Tysabri troubles could continue to cause a drag on Biogen Idec stock, according to a Wall Street Journal report. A recently released research...
Tysabri Safety Info Now Includes PML Cases
Sep 17, 2009
| Parker Waichman LLP
The Food & Drug Administration (FDA) is updating Tysabri safety information to include cases of progressive multifocal leukoencephalopathy or...
Brain Infection Reported in More Tysabri Patients
Sep 15, 2009
| Parker Waichman LLP
Two more Tysabri patients have developed progressive multifocal leukoencephalopathy or PML. Both new cases occurred in European patients,...
10th Tysabri Patient Stricken with PML
Jun 30, 2009
| Parker Waichman LLP
Another Tysabri patient has developed progressive multifocal leukoencephalopathy or PML. This brings the total number of cases of the brain infection...
Another Tysabri Patient Stricken with PML
Jun 15, 2009
| Parker Waichman LLP
Tysabri, a drug used to treat multiple sclerosis, has been linked to another case of progressive multifocal leukoencephalopathy, or...
Tysabri, Plavix Sponsored Link Promotions Criticized
Apr 6, 2009
| Parker Waichman LLP
The makers of Tysabri and Plavix have been warned about internet ads for the drugs. According to the Food & Drug Administration (FDA), the...
Tysabri Linked to Another Case of PML
Oct 30, 2008
| Parker Waichman LLP
Another Tysabri patient has developed progressive multifocal leukoencephalopathy (PML), an often fatal brain disease. Just three months ago,...
Tysabri Labeling Changes Sought by European Regulators
Sep 25, 2008
| Parker Waichman LLP
The European Medicines Agency wants to raise awareness of a deadly brain infection associated with the drug Tysabri. It recommended Thursday...
